148 related articles for article (PubMed ID: 7531876)
21. Modifications in coagulation parameters induced by treatment associating urokinase (2000 u CTA/kg/h) with heparin.
Juhan I; Calas MF; Buonocore M; Mathieu P; Isnard G; Cazenave B; Serradimigni A
Thromb Haemost; 1979 Oct; 42(3):945-54. PubMed ID: 315625
[No Abstract] [Full Text] [Related]
22. [Thrombolytic efficacy of a Lys-plasminogen-urokinase combination: studies in experimental animals and humans].
Latorre J; Foncuberta J; Rosendo A; Elez J
Angiologia; 1990; 42(6):218-26. PubMed ID: 2075946
[TBL] [Abstract][Full Text] [Related]
23. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
Faivre R; Mirshahi M; Ducellier D; Soria C; Soria J; Mirshahi M; Kieffer Y; Bassand JP; Caen J; Maurat JP
Thromb Res; 1988 May; 50(4):583-9. PubMed ID: 3413720
[No Abstract] [Full Text] [Related]
24. Thrombolysis in newborns and infants.
Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
[TBL] [Abstract][Full Text] [Related]
25. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
Wang Y; Liu Q; Zhu J; Yuan Z; Ma X
Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883
[TBL] [Abstract][Full Text] [Related]
26. High-dose urokinase therapy in newborn infants with major vessel thrombosis.
Giacoia GP
Clin Pediatr (Phila); 1993 Apr; 32(4):231-7. PubMed ID: 8462236
[TBL] [Abstract][Full Text] [Related]
27. Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study.
Schweizer J; Elix H; Altmann E; Hellner G; Forkmann L
Vasa; 1998 Aug; 27(3):167-71. PubMed ID: 9747153
[TBL] [Abstract][Full Text] [Related]
28. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis.
Wasay M; Bakshi R; Kojan S; Bobustuc G; Dubey N; Unwin DH
Stroke; 2001 Oct; 32(10):2310-7. PubMed ID: 11588319
[TBL] [Abstract][Full Text] [Related]
29. [Thrombolytic therapy in deep vein phlebitis of the lower limbs].
Malaterre HR; Deharo JC; Daver L; Djiane P
Presse Med; 1994 Jan; 23(3):127-30. PubMed ID: 8177845
[TBL] [Abstract][Full Text] [Related]
30. [Thrombolytic agents].
Furukawa K
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1166-9. PubMed ID: 6503980
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
Carter BL; Jones ME; Waickman LA
Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis.
Goldhaber SZ; Polak JF; Feldstein ML; Meyerovitz MF; Creager MA
Am J Cardiol; 1994 Jan; 73(1):75-9. PubMed ID: 8279382
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of coronary thrombolysis with plasminogen pro-activator by pretreatment with heparin.
Susawa T; Yui Y; Hattori R; Takatsu Y; Yui N; Takahashi M; Aoyama T; Murohara Y; Shirotani M; Kawai C
Jpn Circ J; 1988 Jan; 52(1):72-8. PubMed ID: 3129601
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic use of thrombolytic agents.
Stambaugh RL; Alexander MR
Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic application of contrast-enhanced ultrasound and low-dose urokinase for thrombolysis in a porcine model of acute peripheral arterial occlusion.
Ebben HP; Nederhoed JH; Slikkerveer J; Kamp O; Tangelder GW; Musters RJ; Wisselink W; Yeung KK
J Vasc Surg; 2015 Aug; 62(2):477-85. PubMed ID: 24768365
[TBL] [Abstract][Full Text] [Related]
36. Intra-arterial thrombolysis.
American Society of Interventional and Therapeutic Neuroradiology
AJNR Am J Neuroradiol; 2001 Sep; 22(8 Suppl):S18-21. PubMed ID: 11686069
[No Abstract] [Full Text] [Related]
37. Evaluation of thrombolysis in a porcine model of chronic deep venous thrombosis: an endovascular model.
Lin PH; Chen C; Surowiec SM; Conklin B; Bush RL; Lumsden AB
J Vasc Surg; 2001 Mar; 33(3):621-7. PubMed ID: 11241136
[TBL] [Abstract][Full Text] [Related]
38. [Clinical use of thrombolytic agents].
Laprevote-Heully MC; Lambert H; Larcan A
Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
[No Abstract] [Full Text] [Related]
39. Blood coagulation changes during effective thrombolysis using urokinase and heparin.
Schöffel G; Zimmermann R; Harenberg J; Mörl H
Thromb Res; 1982 Jan 1-15; 25(1-2):11-21. PubMed ID: 6175040
[TBL] [Abstract][Full Text] [Related]
40. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.
Kim HS; Preece SR; Black JH; Pham LD; Streiff MB
J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
